AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that the United States Patent and Trademark Office (USPTO) has recently granted numerous additional composition of matter claims related to the modification of microRNA (miRNA) mimics. The newly granted claims (U.S. Patent No. 8,586,727) will support Mirna’s continued development and commercialization of miRNA-based therapeutics.
Help employers find you! Check out all the jobs and post your resume.
